About Us

MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Our Team

CARL SCHMID

Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C.

cschmid@hivhep.org

Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years.  He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications.

From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). He currently serves as a member of PACHA and as a consumer representative to the National Association of Insurance Commissioners. 

He is a cancer survivor and living with chronic hepatitis B.

Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.

Scott Palmer

Executive Assistant

spalmer@hivhep.org

Ann Lefert

The Lefert Group

Policy Consultant

ann@thelefertgroup.com

Jennifer Burke

Communications Consultant

jburke@hivhep.org

Board Members

CARL SCHMID

President

Executive Director

HIV+Hep Policy Institute

Washington, DC

REKHA RAMESH

Treasurer 

Vice President, Head of Global Policy

Gilead Sciences, Inc.

Foster City, CA

JUSTIN C. SMITH MS, MPH

Secretary

Director, Campaign to End AIDS

Positive Impact Health Centers

Atlanta, GA

ERIN DARLING

Associate Vice President of Federal Policy

Merck

Washington, DC

MARC MEACHEM

Director of External Affairs

ViiV Healthcare

Washington, DC

RAFAELÉ NARVÁEZ

Co-Founder

Latinos Salud

Oakland Park, FL

ANDREW SPERLING

Mental Health Advocate 

Arlington, VA

PAM TRAXEL

Senior Vice President

American Cancer Society

Cancer Action Network

Washington, DC

STEVEN R. YOUNG

Former Director

HIV/AIDS Bureau, HRSA, HHS

Yardley, PA

Funders for HIV+Hepatitis Policy Institute

HIV+Hep appreciates the support of numerous funders, and recognizes those below that are our corporate members and sponsors:

Get Involved

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

@HIVHep thanks members of Congress for introducing the “ #PrEP Assistance Program Act” & the “ #PrEP Access and Coverage Act” and urges more members to cosponsor them in order to build support for these efforts to prevent #HIV: https://t.co/qfYpnJ4krE. https://t.co/4YPT1goJXn HIVHep photo
On @CMSGov’s release of the 2023 NBPP rule, @HIVHep’s Carl Schmid: “CMS sided w/ the powerful insurers & PBMs again by allowing them to collect #copay assistance & not count it towards #patient cost-sharing, thus ↑ the $$ #patients pay for their #Rx”: https://t.co/wqNKQ91bkn. https://t.co/Gel1LhG3OA HIVHep photo
@HIVHep’s Carl Schmid writes in the @sfexaminer that the @POTUS can protect #patients from facing huge out-of-pocket #Rx expenses by making insurers count drug manufacturer copay assistance toward out-of-pocket expenses: https://t.co/SM7d67MBEu. https://t.co/fMYPFlflRj HIVHep photo
@HIVHep’s Carl Schmid writes in @pozmagazine: “2021 was a year of #HIV progress; now let’s focus on #PrEP access . . . . 2 bills in Congress will establish #PrEP progs to prevent HIV. They’re needed to address racial & ethnic disparities in the epidemic”: https://t.co/P9BjSqaSjJ. https://t.co/PXmvAAMANk HIVHep photo
@HIVHep & @AutoimmuneAssoc are asking patient groups to sign a letter commenting in support of proposed @CMSGov rule that requires #insurers to offer standard plan options on the exchange that use reasonable copays for #Rxs to improve affordability: https://t.co/EkyypLRyNC. https://t.co/Z6XTnUjjWy HIVHep photo

Pin It on Pinterest

Share This